$14.23 0.04 (+0.28%)
11/27/2009 1:01 PM

Emergent BioSolutions, Inc. (EBS)

CAPS Rating: 5 out of 5

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

Results 1 - 2 of 2

Recs

0
Member Avatar cjstock02 (20.48) Submitted: 1/28/2009 2:59:20 PM : Underperform Start Price: $21.11 EBS Score: +60.05

We developed a gap down after a long run up. That looks very bearish on the chart.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar KenN513 (87.88) Submitted: 7/16/2007 11:43:02 AM : Underperform Start Price: $11.35 EBS Score: -51.17

Fool ratio is 4.9. Yikes. Are there any new products in the pipeline?

Report this Post 0 Comments | Reply | Permalink
Results 1 - 2 of 2

Featured Broker Partners